ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

XSNX NovAccess Global Inc (QB)

0.0139
0.00 (0.00%)
16 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
NovAccess Global Inc (QB) USOTC:XSNX OTCMarkets Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.0139 0.0075 0.0145 0.0139 0.0139 0.0139 80,678 21:38:29

Statement of Changes in Beneficial Ownership (4)

09/09/2020 9:48pm

Edgar (US Regulatory)


FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Martin Daniel G.
2. Issuer Name and Ticker or Trading Symbol

NovAccess Global Inc. [ XSNX ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__X__ Director                    __X__ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
Chief Executive Officer
(Last)          (First)          (Middle)

8834 MAYFIELD RD
3. Date of Earliest Transaction (MM/DD/YYYY)

9/4/2020
(Street)

CHESTERLAND, OH 44026
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Series A Preferred Stock, $0.01 par value per share 9/4/2020  J(1)  5000 D$0 0 I By TN3, LLC 
Series B Preferred Stock, $0.01 par value per share 9/4/2020  J(1)  25000 A$0 25000 I By TN3, LLC 
Common Stock, no par value 9/8/2020  J(2)  7500000 A$0 7500000 I By Innovest Global, Inc. 

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security3. Trans. Date3A. Deemed Execution Date, if any4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Series B Preferred Stock, $0.01 par value $0 9/8/2020  J (2)  25000    9/8/2020  (3)Common Stock, no par value 250000000 $0 25000 I By TN3, LLC 

Explanation of Responses:
(1) On September 4, 2020, NovAccess Global Inc. (the "Company") redeemed 5,000 shares of Series A preferred stock held by TN3, LLC ("TN3") for 25,000 shares of the Company's Series B preferred stock. The holder of the Company's shares of Series A preferred is entitled to cast a number of votes equal to that number of common shares of the Company which is not less than 60% of the vote required to approve an action on all matters voted on the Company's shareholders. Each share of Series B preferred in convertible by the holder into 10,000 shares of the Company's common stock and entitles the holder to cast 40,000 votes on all matters voted on by the Company's shareholders.
(2) On September 8, 2020, the Company issued 7,500,000 shares of common stock to Innovest Global, Inc. ("Innovest") for all of the outstanding interests of StemVax, LLC. Mr. Martin is the chairman and a significant shareholder of Innovest. Mr. Martin disclaims beneficial ownership of the shares of the Company's common stock held by Innovest.
(3) None.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Martin Daniel G.
8834 MAYFIELD RD
CHESTERLAND, OH 44026
XXChief Executive Officer

Signatures
/s/ Daniel G. Martin9/9/2020
**Signature of Reporting PersonDate

1 Year NovAccess Global (QB) Chart

1 Year NovAccess Global (QB) Chart

1 Month NovAccess Global (QB) Chart

1 Month NovAccess Global (QB) Chart

Your Recent History

Delayed Upgrade Clock